Jump to content

Category:Anti-diabetic drugs

From Wikipedia, the free encyclopedia

Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10)

Insulins / insulin analogs

fast-acting	Insulin aspart Insulin glulisine Insulin lispro
short-acting	Regular insulin^#
long-acting	Insulin detemir^# Insulin glargine^# (+lixisenatide) NPH insulin Lente insulin^‡ Ultralente insulin^‡
ultra-long-acting	Insulin degludec^# (+insulin aspart, +liraglutide) Insulin icodec^† (+semaglutide)
inhalable	Exubera^‡ Afrezza

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Non-insulins

Insulin sensitizers

Biguanides	Buformin^‡ Metformin^# Phenformin^‡
TZDs/"glitazones" (PPAR)	Ciglitazone^§ Darglitazone^§ Englitazone^§ Lobeglitazone Netoglitazone^§ Pioglitazone Rivoglitazone^† Rosiglitazone Troglitazone^‡
Dual PPAR agonists	Aleglitazar^† Muraglitazar^§ Saroglitazar Tesaglitazar^§
Amylin analogs and DACRAs	Cagrilintide^§ Pramlintide

Sulfonylureas	1st generation: Acetohexamide Carbutamide Chlorpropamide Glycyclamide Metahexamide Tolazamide Tolbutamide 2nd generation: Glibenclamide (glyburide) Glibornuride Glicaramide Gliclazide^# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide
Meglitinides/"glinides"	Mitiglinide Nateglinide Repaglinide

GLP-1 receptor agonists

GLP1 poly-agonist peptides	Mazdutide (GLP-1/GCGR) Retatrutide^§ (GLP-1/GIP/GCGR) Tirzepatide (GLP-1/GIP)

DPP-4 inhibitors/"gliptins"

Other

Aldose reductase inhibitors	Epalrestat Fidarestat^§ Ranirestat^† Tolrestat^‡ Zenarestat^§
Alpha-glucosidase inhibitors	Acarbose Miglitol Voglibose
SGLT2 inhibitors/"gliflozins"	Canagliflozin Dapagliflozin Empagliflozin^# Ertugliflozin Ipragliflozin Luseogliflozin Remogliflozin^§ Sergliflozin^§ Sotagliflozin Tofogliflozin^† Velagliflozin
Other	Benfluorex^‡ Bromocriptine Imeglimin

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This category reflects the organization of Anatomical Therapeutic Chemical Classification System code A10.
Generally, drugs outlined within the ATC code A10 should be included in this category.
Please see WP:PHARM:CAT for more information.

Wikimedia Commons has media related to Anti-diabetic drugs.

Subcategories

This category has the following 12 subcategories, out of 12 total.

A

Alpha-glucosidase inhibitors (6 P)
Amylin receptor agonists (8 P)

B

Biguanides (18 P)

C

Combination diabetes drugs (19 P)

D

Dipeptidyl peptidase-4 inhibitors (22 P)

E

Experimental diabetes drugs (29 P)

G

GLP-1 receptor agonists (35 P)

I

Insulin receptor agonists (28 P)

M

Meglitinides (4 P)

S

SGLT2 inhibitors (27 P)
Sulfonylureas (2 C, 6 P)

T

Thiazolidinediones (13 P)

Pages in category "Anti-diabetic drugs"

The following 14 pages are in this category, out of 14 total. This list may not reflect recent changes.

A

D

Dasiglucagon

G

H

Henagliflozin

I

Imeglimin

J

Janagliflozin

M

Metformin

S

SGLT2 inhibitor

T

Trecadrine

Retrieved from "https://en.wikipedia.org/w/index.php?title=Category:Anti-diabetic_drugs&oldid=1187879484"

Hidden category:

Commons category link is on Wikidata